SCHEMBL3682900

SCHEMBL3682900

Brc1ccc2c3c(ccc(Br)c13)-c1c-2c(-c2ccccc2)c2ccccc2c1-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.41
KDM4E B2RXH2 2/20 0.41
MAPT P10636 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ALDH1A1 P00352 3/20 0.39
ESR1 P03372 3/20 0.37
ESR2 Q92731 3/20 0.37
CYP1A2 P05177 2/20 0.35
CYP1B1 Q16678 4/20 0.35
EGFR P00533 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
ACHE P22303 1/20 0.33
HPGD P15428 1/20 0.33
PARP1 P09874 1/20 0.32
LMNA P02545 1/20 0.32
HTT P42858 1/20 0.32
ENPP1 P22413 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13318342 0.94 MAPK1 (0.40) MAPK1KDM4EMAPTTDP1L3MBTL1
SCHEMBL2201457 0.93 MAPK1 (0.41) MAPK1KDM4EMAPTTDP1L3MBTL1
SCHEMBL13318335 0.92 MAPK1 (0.41) MAPK1KDM4EMAPTTDP1L3MBTL1
SCHEMBL2200391 0.88 MAPT (0.36) MAPK1KDM4EMAPTTDP1L3MBTL1
SCHEMBL13318271 0.86 CYP1A1 (0.38) MAPK1KDM4EMAPTTDP1L3MBTL1
SCHEMBL30170061 0.85 CYP1A2 (0.51) MAPK1KDM4EMAPTTDP1L3MBTL1
SCHEMBL959783 0.85 CYP1A2 (0.51) MAPK1KDM4EMAPTTDP1L3MBTL1
SCHEMBL12449294 0.84 CYP1A2 (0.41) MAPK1KDM4EMAPTTDP1L3MBTL1
SCHEMBL2865816 0.84 PARP1 (0.41) MAPK1KDM4EMAPTTDP1L3MBTL1
SCHEMBL12449293 0.82 CYP1A2 (0.45) MAPK1KDM4EMAPTTDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7732652-B2 Perylene derivative synthesis process, perylene derivative and organic EL device TDK CORPORATION (JP) 2010-06-08 US disclosed
US-7732652-B2 Perylene derivative synthesis process, perylene derivative and organic EL device TDK CORPORATION (JP) 2010-06-08 US disclosed
US-7732652-B2 Perylene derivative synthesis process, perylene derivative and organic EL device TDK CORPORATION (JP) 2010-06-08 US disclosed
US-7318965-B2 Perylene derivative synthesis process, perylene derivative and organic EL device TDK CORPORATION (JP) 2008-01-15 US disclosed
US-7318965-B2 Perylene derivative synthesis process, perylene derivative and organic EL device TDK CORPORATION (JP) 2008-01-15 US disclosed
US-7318965-B2 Perylene derivative synthesis process, perylene derivative and organic EL device TDK CORPORATION (JP) 2008-01-15 US disclosed
US-20050054852-A1 Perylene derivative synthesis process, perylene derivative and organic EL device TDK CORPORATION (JP) 2005-03-10 US disclosed
US-20030137241-A1 Perylene derivative synthesis process, perylene derivative and organic EL device TDK CORPORATION (JP) 2003-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030137241-A1 Perylene derivative synthesis process, perylene derivative and organic EL device CPNE4, EED, ELOC MAPK1 2346/4885KDM4E 206/4885MAPT 1823/4885
US-20050054852-A1 Perylene derivative synthesis process, perylene derivative and organic EL device ENY2, SCO2, AOC3 MAPK1 1446/4885KDM4E 2978/4885MAPT 4554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.